During this episode of Biotalk,Geoff Meyerson, CEO ofLocust Walk, unpacks our2024 Q1 Report: Global Trends in Biopharma Transactions Report.Each quarter, Locust Walks deal team compiles key stati

In this episode, Geoff provides valuable insights into our report, focusing on critical areas such as: Biotech capital markets: XBI performance and IPO volume Private biotech markets: Financing

On this episode of Biotalk,Locust WalksGeoff MeyersonwelcomesSoufiane Aboulhouda, Co-Founder and Chairman of the Board ofNucleate, a global non-profit dedicated to empowering future biotech lead

On this episode of Biotalk,Locust WalksDaniel Brogwelcomes withShehnaaz Suliman, M.D., CEO ofReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting l

On this episode of Biotalk,Locust WalksGeoff MeyersonwelcomesErrik Anderson, CEO and Founder ofAlloy Therapeutics, to the podcast. Alloy is a trailblazing drug-discovery company, bringing collab